Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

BCRX BioCryst Pharmaceuticals Inc

7,43

0,04 (0,54%)

Zuletzt aktualisiert: 20:35:31

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more BioCryst Pharmaceuticals Charts.

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more BioCryst Pharmaceuticals Charts.

News BioCryst Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 16 Dezember 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 13 Dezember 2024 (7 Tage vor) • Edgar (US Regulatory)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mittwoch 4 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 2 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

BioCryst Launches ORLADEYO® (berotralstat) in Ireland
Montag 18 November 2024 (1 Monat vor) • GlobeNewswire Inc.

BioCryst to Present at Upcoming Investor Conferences
Mittwoch 6 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 5 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere BioCryst Pharmaceuticals Inc News-Artikel

BNP Paribas (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen